Researchers reveal fibrin’s critical role in COVID-19 by driving thromboinflammation and neuropathology, and highlight a potential antibody therapy to mitigate these effects.
Mikael Dolsten isn’t the only one moving on from Pfizer; Lilly names interim finance chief
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS